These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
246 related articles for article (PubMed ID: 34096413)
1. Thrombolysis outcomes according to arterial characteristics of acute ischemic stroke by alteplase dose and blood pressure target. Zhou Z; Xia C; Mair G; Delcourt C; Yoshimura S; Liu X; Chen Z; Malavera A; Carcel C; Chen X; Wang X; Al-Shahi Salman R; Robinson TG; Lindley RI; Chalmers J; Wardlaw JM; Parsons MW; Demchuk AM; Anderson CS Int J Stroke; 2022 Jun; 17(5):566-575. PubMed ID: 34096413 [TBL] [Abstract][Full Text] [Related]
2. Intensive blood pressure reduction with intravenous thrombolysis therapy for acute ischaemic stroke (ENCHANTED): an international, randomised, open-label, blinded-endpoint, phase 3 trial. Anderson CS; Huang Y; Lindley RI; Chen X; Arima H; Chen G; Li Q; Billot L; Delcourt C; Bath PM; Broderick JP; Demchuk AM; Donnan GA; Durham AC; Lavados PM; Lee TH; Levi C; Martins SO; Olavarria VV; Pandian JD; Parsons MW; Pontes-Neto OM; Ricci S; Sato S; Sharma VK; Silva F; Song L; Thang NH; Wardlaw JM; Wang JG; Wang X; Woodward M; Chalmers J; Robinson TG; Lancet; 2019 Mar; 393(10174):877-888. PubMed ID: 30739745 [TBL] [Abstract][Full Text] [Related]
3. Interaction of Blood Pressure Lowering and Alteplase Dose in Acute Ischemic Stroke: Results of the Enhanced Control of Hypertension and Thrombolysis Stroke Study. Wang X; Song L; Yang J; Sun L; Moullaali TJ; Sandset EC; Delcourt C; Lindley RI; Robinson TG; Minhas JS; Arima H; Chalmers J; Kim JS; Sharma V; Wang JG; Pontes-Neto O; Lavados PM; Olavarría VV; Lee TH; Levi C; Martins SO; Thang NH; Anderson CS; Cerebrovasc Dis; 2019; 48(3-6):207-216. PubMed ID: 31812956 [TBL] [Abstract][Full Text] [Related]
4. Low- Versus Standard-Dose Alteplase in Patients on Prior Antiplatelet Therapy: The ENCHANTED Trial (Enhanced Control of Hypertension and Thrombolysis Stroke Study). Robinson TG; Wang X; Arima H; Bath PM; Billot L; Broderick JP; Demchuk AM; Donnan GA; Kim JS; Lavados PM; Lee TH; Lindley RI; Martins SCO; Olavarria VV; Pandian JD; Parsons MW; Pontes-Neto OM; Ricci S; Sato S; Sharma VK; Nguyen TH; Wang JG; Woodward M; Chalmers J; Anderson CS; Stroke; 2017 Jul; 48(7):1877-1883. PubMed ID: 28619989 [TBL] [Abstract][Full Text] [Related]
5. Rationale, design, and progress of the ENhanced Control of Hypertension ANd Thrombolysis strokE stuDy (ENCHANTED) trial: An international multicenter 2 × 2 quasi-factorial randomized controlled trial of low- vs. standard-dose rt-PA and early intensive vs. guideline-recommended blood pressure lowering in patients with acute ischaemic stroke eligible for thrombolysis treatment. Huang Y; Sharma VK; Robinson T; Lindley RI; Chen X; Kim JS; Lavados P; Olavarría V; Arima H; Fuentes S; Nguyen HT; Lee TH; Parsons MW; Levi C; Demchuk AM; Bath PM; Broderick JP; Donnan GA; Martins S; Pontes-Neto OM; Silva F; Pandian J; Ricci S; Stapf C; Woodward M; Wang J; Chalmers J; Anderson CS; Int J Stroke; 2015 Jul; 10(5):778-88. PubMed ID: 25832995 [TBL] [Abstract][Full Text] [Related]
6. Influence of Renal Impairment on Outcome for Thrombolysis-Treated Acute Ischemic Stroke: ENCHANTED (Enhanced Control of Hypertension and Thrombolysis Stroke Study) Post Hoc Analysis. Carr SJ; Wang X; Olavarria VV; Lavados PM; Rodriguez JA; Kim JS; Lee TH; Lindley RI; Pontes-Neto OM; Ricci S; Sato S; Sharma VK; Woodward M; Chalmers J; Anderson CS; Robinson TG; Stroke; 2017 Sep; 48(9):2605-2609. PubMed ID: 28739832 [TBL] [Abstract][Full Text] [Related]
7. Comparative effects of low-dose versus standard-dose alteplase in ischemic patients with prior stroke and/or diabetes mellitus: The ENCHANTED trial. Chen G; Wang X; Robinson TG; Pikkemaat M; Lindley RI; Zhou S; Ping L; Liu W; Liu L; Chalmers J; Anderson CS; J Neurol Sci; 2018 Apr; 387():1-5. PubMed ID: 29571842 [TBL] [Abstract][Full Text] [Related]
8. Twenty-Four-Hour Post-Thrombolysis NIHSS Score As the Strongest Prognostic Predictor After Acute Ischemic Stroke: ENCHANTED Study. You S; Wang Y; Wang X; Maeda T; Ouyang M; Han Q; Li Q; Song L; Zhao Y; Chen C; Delcourt C; Ren X; Carcel C; Zhou Z; Cao Y; Liu CF; Zheng D; Arima H; Robinson TG; Chen X; Lindley RI; Chalmers J; Anderson CS J Am Heart Assoc; 2024 Sep; 13(18):e036109. PubMed ID: 39258531 [TBL] [Abstract][Full Text] [Related]
9. Ethnicity and Other Determinants of Quality of Functional Outcome in Acute Ischemic Stroke: The ENCHANTED Trial. Chen X; Wang X; Delcourt C; Li J; Arima H; Hackett ML; Robinson T; Lavados PM; Lindley RI; Chalmers J; Anderson CS; Stroke; 2020 Feb; 51(2):588-593. PubMed ID: 31822251 [TBL] [Abstract][Full Text] [Related]
15. Intensive versus guideline-recommended blood pressure reduction in acute lacunar stroke with intravenous thrombolysis therapy: The ENCHANTED trial. Zhou Z; Xia C; Carcel C; Yoshimura S; Wang X; Delcourt C; Malavera A; Chen X; Mair G; Woodward M; Chalmers J; Demchuk AM; Lindley RI; Robinson TG; Parsons MW; Wardlaw JM; Anderson CS Eur J Neurol; 2021 Mar; 28(3):783-793. PubMed ID: 33069172 [TBL] [Abstract][Full Text] [Related]
16. Disparities between Asian and Non-Asian Thrombolyzed Acute Ischemic Stroke Patients in the Enhanced Control of Hypertension and Thrombolysis Stroke Trial. Chen C; Wang X; Chen X; Ouyang M; Sun L; Arima H; Robinson T; Lindley RI; Chalmers J; Li G; Song L; Anderson CS; Cerebrovasc Dis; 2021; 50(5):560-566. PubMed ID: 34153968 [TBL] [Abstract][Full Text] [Related]
17. Low-Dose vs Standard-Dose Alteplase for Patients With Acute Ischemic Stroke: Secondary Analysis of the ENCHANTED Randomized Clinical Trial. Wang X; Robinson TG; Lee TH; Li Q; Arima H; Bath PM; Billot L; Broderick J; Demchuk AM; Donnan G; Kim JS; Lavados P; Lindley RI; Martins SO; Olavarria VV; Pandian JD; Parsons MW; Pontes-Neto OM; Ricci S; Sharma VK; Thang NH; Wang JG; Woodward M; Anderson CS; Chalmers J; JAMA Neurol; 2017 Nov; 74(11):1328-1335. PubMed ID: 28973174 [TBL] [Abstract][Full Text] [Related]
18. Effect of Time to Thrombolysis on Clinical Outcomes in Patients With Acute Ischemic Stroke Treated With Tenecteplase Compared to Alteplase: Analysis From the AcT Randomized Controlled Trial. Singh N; Almekhlafi MA; Bala F; Ademola A; Coutts SB; Deschaintre Y; Khosravani H; Buck B; Appireddy R; Moreau F; Gubitz G; Tkach A; Catanese L; Dowlatshahi D; Medvedev G; Mandzia J; Pikula A; Shankar JJ; Ghrooda E; Poppe AY; Williams H; Field TS; Manosalva A; Siddiqui MM; Zafar A; Imoukhoude O; Hunter G; Shamy M; Demchuk AM; Claggett BL; Hill MD; Sajobi TT; Swartz RH; Menon BK Stroke; 2023 Nov; 54(11):2766-2775. PubMed ID: 37800372 [TBL] [Abstract][Full Text] [Related]
19. Statistical analysis plan for evaluating low- vs. standard-dose alteplase in the ENhanced Control of Hypertension and Thrombolysis strokE stuDy (ENCHANTED). Anderson CS; Woodward M; Arima H; Chen X; Lindley RI; Wang X; Chalmers J; Int J Stroke; 2015 Dec; 10(8):1313-5. PubMed ID: 26283139 [TBL] [Abstract][Full Text] [Related]
20. Brain Imaging Signs and Health-Related Quality of Life after Acute Ischemic Stroke: Analysis of ENCHANTED Alteplase Dose Arm. Chen X; Delcourt C; Sun L; Zhou Z; Yoshimura S; You S; Malavera A; Torii-Yoshimura T; Carcel C; Arima H; Hackett ML; Robinson T; Song L; Wang X; Lindley RI; Chalmers J; Anderson CS; Cerebrovasc Dis; 2020; 49(4):427-436. PubMed ID: 32702699 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]